These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 30649024)
1. Current status of familial hypercholesterolemia in Chinese populations. Tomlinson B; Hu M; Chow E Curr Opin Lipidol; 2019 Apr; 30(2):94-100. PubMed ID: 30649024 [TBL] [Abstract][Full Text] [Related]
2. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia. Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356 [TBL] [Abstract][Full Text] [Related]
4. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
5. Familial hypercholesterolaemia: different perspectives. Jones JL; Lakasing E; Archontakis S Nurs Stand; 2009 Aug 19-25; 23(50):35-8. PubMed ID: 19736707 [TBL] [Abstract][Full Text] [Related]
6. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab. Thedrez A; Blom DJ; Ramin-Mangata S; Blanchard V; Croyal M; Chemello K; Nativel B; Pichelin M; Cariou B; Bourane S; Tang L; Farnier M; Raal FJ; Lambert G Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):592-598. PubMed ID: 29284604 [TBL] [Abstract][Full Text] [Related]
7. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol. Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564 [TBL] [Abstract][Full Text] [Related]
8. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship. Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735 [TBL] [Abstract][Full Text] [Related]
9. Familial hypercholesterolemia: current treatment and advances in management. Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545 [TBL] [Abstract][Full Text] [Related]
10. Recently reported familial hypercholesterolemia-related mutations from cases in the Middle East and North Africa region. Awan ZA; Bondagji NS; Bamimore MA Curr Opin Lipidol; 2019 Apr; 30(2):88-93. PubMed ID: 30694837 [TBL] [Abstract][Full Text] [Related]
16. Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe. Ruel I; Aljenedil S; Sadri I; de Varennes É; Hegele RA; Couture P; Bergeron J; Wanneh E; Baass A; Dufour R; Gaudet D; Brisson D; Brunham LR; Francis GA; Cermakova L; Brophy JM; Ryomoto A; Mancini GBJ; Genest J Clin Chem; 2018 Feb; 64(2):355-362. PubMed ID: 29038147 [TBL] [Abstract][Full Text] [Related]
17. Compound heterozygous familial hypercholesterolemia in a Chinese boy with a de novo and transmitted low-density lipoprotein receptor mutation. Ma Y; Gong Y; Garg A; Zhou H J Clin Lipidol; 2018; 12(1):230-235.e6. PubMed ID: 29233637 [TBL] [Abstract][Full Text] [Related]
18. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia. Heath KE; Gudnason V; Humphries SE; Seed M Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479 [TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia. Leitersdorf E; Eisenberg S; Eliav O; Friedlander Y; Berkman N; Dann EJ; Landsberger D; Sehayek E; Meiner V; Wurm M Circulation; 1993 Apr; 87(4 Suppl):III35-44. PubMed ID: 8462179 [TBL] [Abstract][Full Text] [Related]
20. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia. Couture P; Brun LD; Szots F; Lelièvre M; Gaudet D; Després JP; Simard J; Lupien PJ; Gagné C Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1007-12. PubMed ID: 9633944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]